CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 5991-5998

  Sugimoto, Kyoko ^a   Murata, Makoto ^a   Terakura, Seitaro ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER TRANSPLANTATION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MUTANT; CLONE; CYTOKINE PRODUCTION; CYTOLYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOLECULAR RECOGNITION; ORGAN DONOR; PHENOTYPE; PRIORITY JOURNAL; WHOLE BODY RADIATION; WILD TYPE;

ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; HLA-C ANTIGENS; HUMANS; ISOANTIGENS; MINOR HISTOCOMPATIBILITY LOCI; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77954156358     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804310     Document Type: Article

References (34)

1. Petersdorf, E. W. 2004. HLA matching in allogeneic stem cell transplantation. Curr. Opin. Hematol. 11: 386-391.
2. Morishima, Y., T. Sasazuki, H. Inoko, T. Juji, T. Akaza, K. Yamamoto, Y. Ishikawa, S. Kato, H. Sao, H. Sakamaki, et al. 2002. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99: 4200-4206.
3. Flomenberg, N., L. A. Baxter-Lowe, D. Confer, M. Fernandez-Vina, A. Filipovich, M. Horowitz, C. Hurley, C. Kollman, C. Anasetti, H. Noreen, et al. 2004. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104: 1923-1930.
4. Morishima, Y., T. Yabe, K. Matsuo, K. Kashiwase, H. Inoko, H. Saji, K. Yamamoto, E. Maruya, Y. Akatsuka, M. Onizuka, H. Sakamaki, et al. 2007. Japan Marrow Donor Program: effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol. Blood Marrow Transplant. 13: 315-428.
5. Kaminski, E. R. 1989. How important is histocompatibility in bone marrow transplantation? Bone Marrow Transplant. 4: 439-444.
6. Goulmy, E. 1997. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157: 125-140. (Pubitemid 27303125)
7. Riddell, S. R., C. Berger, M. Murata, S. Randolph, and E. H. Warren. 2003. The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Rev. 17: 153-162.
8. Kariyone, A., M. Tanabe, T. Juji, K. Kano, and M. Takiguchi. 1990. Functional expression of HLA-C blank antigens on human blood lymphocytes. J. Immunol. 145: 3714-3718.
9. Rufer, N., B. S. Breur-Vriesendorp, J. M. Tiercy, A. S. Slavcev, N. M. Lardy, P. Francis, R. Kressig, D. E. Speiser, C. Helg, B. Chapuis, et al. 1993. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs: analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing, and HLA oligotyping. Hum. Immunol. 38: 235-239.
10. Barnardo, M. C., N. J. Davey, M. Bunce, P. A. Brookes, R. I. Lechler, K. I. Welsh, and J. R. Batchelor. 1996. A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 61: 1420-1423.
11. Grundschober, C., N. Rufer, A. Sanchez-Mazas, A. Madrigal, M. Jeannet, E. Roosnek, and J. M. Tiercy. 1997. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs: sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes. Tissue Antigens 49: 612-623.
12. Yazaki, M., T. Takahashi, K. Mizutani, Y. Ito, H. Wakiguchi, M. Inoue, K. Kawa, K. Kato, T. Kato, H. Saito, and H. Togari. 2002. Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation. Br. J. Haematol. 117: 893-898.
13. McCutcheon, J. A., J. Gumperz, K. D. Smith, C. T. Lutz, and P. Parham. 1995. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181: 2085-2095.
14. Neisig, A., C. J. Melief, and J. Neefjes. 1998. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160: 171-179. (Pubitemid 28116727)
15. David, R. J. 2003. Locus-specific constitutive and cytokine-induced HLA class I gene expression. J. Immunol. 170: 1894-1902.
16. Przepiorka, D., D. Weisdorf, P. Martin, H. G. Klingemann, P. Beatty, J. Hows, and E. D. Thomas. 1995. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 15: 825-828.
17. Murata, M., E. H. Warren, and S. R. Riddell. 2003. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197: 1279-1289.
18. Riddell, R. S., M. Rabin, A. P. Geballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146: 2795-2804.
19. Narimatsu, H., M. Murata, S. Terakura, K. Sugimoto, and T. Naoe. 2008. Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation. Biol. Blood Marrow Transplant. 14: 397-402.
20. Whitelegg, A., and L. D. Barber. 2004. The structural basis of T-cell allorecognition. Tissue Antigens 63: 101-108.
21. Steven, G. E., P. Peter, and D. B. Linda. 2000. The HLA Facts Book. London: Academic Press.
22. Zhao, B., A. E. Png, E. C. Ren, P. R. Kolatkar, V. S. Mathura, M. K. Sakharkar, and P. Kangueane. 2003. Compression of functional space in HLA-A sequence diversity. Hum. Immunol. 64: 718-728.
23. Sasazuki, T., T. Juji, Y. Morishima, N. Kinukawa, H. Kashiwabara, H. Inoko, T. Yoshida, A. Kimura, T. Akaza, N. Kamikawaji, Y. Kodera, and F. Takaku. 1998. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N. Engl. J. Med. 339: 1177-1185.
24. Lee, S. J., J. Klein, M. Haagenson, L. A. Baxter-Lowe, D. L. Confer, M. Eapen, M. Fernandez-Vina, N. Flomenberg, M. Horowitz, C. K. Hurley, et al. 2007. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110: 4576-4583.
25. Tiercy, J. M., J. Passweg, A. van Biezen, A. Zander, N. Kröger, A. Gratwohl, B. Chapuis, C. Helg, L. Brinch, J. Cornelissen, et al. 2004. Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT): isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant. 34: 249-255.
26. van der Meer, A., I. Joosten, A. V. Schattenberg, T. J. de Witte, and W. A. Allebes. 2000. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation. Br. J. Haematol. 111: 685-694.
27. Spencer, A., R. M. Szydlo, P. A. Brookes, E. Kaminski, S. Rule, F. van Rhee, K. N. Ward, G. Hale, H. Waldmann, J. M. Hows, J. R. Batchelor, and J. M. Goldman. 1995. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 86: 3590-3597.
28. Kaminski, E., J. Hows, S. Man, P. Brookes, S. Mackinnon, T. Hughes, O. Avakian, J. M. Goldman, and J. R. Batchelor. 1989. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48: 608-613.
29. Speiser, D. E., C. C. Löliger, M. K. Siren, and M. Jeannet. 1996. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. Br. J. Haematol. 93: 935-939.
30. + peripheral blood T cells. Blood 82: 1546-1552.
31. + double positive (DP) T cells in health and disease. Autoimmun. Rev. 3: 215-220.
32. O'Keefe, C. L., L. Gondek, R. Davis, E. Kuczkowski, R. M. Sobecks, A. Rodriguez, Y. Narvaez, Z. McIver, R. Tuthill, M. Laughlin, B. Bolwell, and J. P. Maciejewski. 2007. Molecular analysis of alloreactive CTL post-hemopoietic stem cell transplantation. J. Immunol. 179: 2013-2022.
33. Kawase, T., Y. Morishima, K. Matsuo, K. Kashiwase, H. Inoko, H. Saji, S. Kato, T. Juji, Y. Kodera, and T. Sasazuki. 2007. Japan Marrow Donor Program: highrisk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 110: 2235-2241.
34. Colonna, M., E. G. Brooks, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260: 1121-1124. (Pubitemid 23186786)